Immunotherapy in melanoma

Immunotherapy
Emily Feld, Tara C Mitchell

Abstract

Immunotherapy has dramatically improved the prognosis for patients with melanoma and has become the cornerstone of treatment for those with advanced disease. The role of immunotherapy continues to expand with multiple new agents approved in the adjuvant as well as metastatic setting, as first-line therapy and beyond. We review the currently approved drugs for the treatment of melanoma, along with clinical trial data, adverse side effects, response assessment and future directions.

References

Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M KirkwoodR H Blum
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John M KirkwoodUNKNOWN Eastern Cooperative Oncology Group
Feb 9, 2006·Current Opinion in Immunology·Karl S PeggsJames P Allison
Oct 9, 2007·Cancer Treatment Reviews·Philip LuiThomas R Einarson
May 27, 2008·Nature Reviews. Immunology·Weiping Zou, Lieping Chen
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberEvan Hersh
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·David R MinorMohammed Kashani-Sabet
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Apr 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberMary L Disis
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert H I AndtbackaRobert S Coffin
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Mar 10, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiJedd D Wolchok
Apr 20, 2016·JAMA : the Journal of the American Medical Association·Antoni RibasCaroline Robert
Apr 29, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MansonR Houot
May 29, 2016·Seminars in Diagnostic Pathology·Mark R Wick, Alejandro A Gru
Jul 2, 2016·JAMA Oncology·Claire F FriedmanMichael A Postow
Oct 8, 2016·Future Oncology·Giuliano PalumboVincenzo Damiano
Oct 9, 2016·The New England Journal of Medicine·Alexander M M EggermontAlessandro Testori
Oct 16, 2016·Expert Opinion on Drug Safety·Egle RamelyteReinhard Dummer
Nov 16, 2016·Journal of Immunotherapy·Douglas B JohnsonRyan J Sullivan
Nov 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudOmid Hamid
Jan 28, 2017·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Tyler OklandRobert P Dellavalle
May 19, 2017·Journal for Immunotherapy of Cancer·Tomoko FreshwaterJulie A Stone
May 26, 2017·American Journal of Clinical Dermatology·Antonio M GrimaldiPaolo A Ascierto
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Ahmad A TarhiniSancy Leachman
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Cardinale B SmithThomas J Smith

❮ Previous
Next ❯

Citations

Mar 16, 2019·International Journal of Cancer. Journal International Du Cancer·Ziqian LiJun Du
Oct 17, 2019·Nanomaterials·Jacinta Oliveira PinhoMaria Manuela Gaspar
Sep 12, 2020·Cells·Alessandro RizzoFrancesco Massari
Jan 13, 2021·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L Kuntz, G Noel
Jan 20, 2021·The Journal of the American Dental Association·Dani StanboulyScott M Peters

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01667419
NCT01682083
NCT02388906
NCT02362594
NCT02506153
NCT01274338
NCT02910700
NCT02130466
NCT02908672
NCT01968109

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Biology & Therapy
Martina SanlorenzoSusanna Ortiz-Urda
The Journal of Urology
John S LamArie S Belldegrun
Recent Patents on Cardiovascular Drug Discovery
Ashwani Kumar, John Kao
The Cancer Journal
Barbara S CraftStacy L Moulder
© 2022 Meta ULC. All rights reserved